Drugmakers to raise US prices on over 250 medicines starting Jan. 1

Reuters – Tuesday, December 31, 2024
By Michael Erman

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb’s cancer cell therapies and vaccines from France’s Sanofi at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors.

Click here to read the entire article.